Citation: | ZHANG Xiaojiao, ZHANG Hailong, XIANG Youqin, DING Jinsong. Dose dumping of levomilnacipran hydrochloride sustained-release capsules[J]. Journal of China Pharmaceutical University, 2022, 53(1): 60-66. DOI: 10.11665/j.issn.1000-5048.20220109 |
[1] |
.
|
[2] |
FDA. Information for healthcare professionals: hydromorphone hydrochloride extended-release capsules(marketed as Palladone)[EB/OL].
|
[3] |
Murray S,Wooltorton E. Alcohol-associated rapid release of a long-acting opioid[J]. CMAJ,2005,173(7): 756.
|
[4] |
Darke AC. Controlled-release opioids and alcohol[J]. CMAJ,2006,174(3):352.
|
[5] |
Anand O,Yu LX,Conner DP,et al. Dissolution testing for generic drugs:an FDA perspective[J]. AAPS J,2011,13(3):328-335.
|
[6] |
PMDA.Regarding concepts on bioequivalence test of production change of oral solid preparation[EB].[
|
[7] |
FDA.Levomilnacipran[EB/OL].[
|
[8] |
Hair P,Cameron F,Garnock-Jones KP. Levomilnacipran extended release:first global approval[J]. Drugs,2013,73(14):1639-1645.
|
[9] |
He S,Yang XM,Li HF. New antidepressant:levomilnacipran[J].Chin J New Drugs Clin Med(中国新药与临床杂志),2015,34(6):418-422.
|
[10] |
Surana R,Divi M,Chhettry A. Stable dosage forms of levomilnacipran:
US8481598[P]. |
[11] |
Narisawa S,Yoshino H,Hirakawa Y,et al. Porosity-controlled ethylcellulose film coating. I. formation of porous ethylcellulose film in the casting process and factors affecting film-density[J]. Chem Pharm Bull,1993,41(2):329-334.
|
[1] | SHI Qinqing, WANG Jinghua, CHENG Manman, YIN Lifang, QIN Chao. Preparation and in vitro release of ivabradine hydrochloride elementary osmotic pump tablets[J]. Journal of China Pharmaceutical University, 2021, 52(3): 311-317. DOI: 10.11665/j.issn.1000-5048.20210307 |
[2] | SUN Jundi, ZHANG Ziqiang, HE Shuwang, YAO Jing. Progress on novel pediatric oral solid dosage forms[J]. Journal of China Pharmaceutical University, 2019, 50(6): 631-640. DOI: 10.11665/j.issn.1000-5048.20190601 |
[3] | LIN Xia, LI Qibin, SHI Xiaoyu, YANG Ziyi. Preparation and evaluation of long-acting injectable formulations of memantine[J]. Journal of China Pharmaceutical University, 2018, 49(5): 587-595. DOI: 10.11665/j.issn.1000-5048.20180511 |
[4] | SHAO Hua, SONG Yifan, HE Jie, HU Linlin. Pharmacokinetics and drug concentration monitoring of high-dose tigecycline in patients with septic shock[J]. Journal of China Pharmaceutical University, 2017, 48(6): 721-726. DOI: 10.11665/j.issn.1000-5048.20170614 |
[5] | Preparation and formulation optimization of silymarin sustained-release tablets[J]. Journal of China Pharmaceutical University, 2010, 41(4): 348-352. |
[6] | DING Li, ZHANG Jun-shou. HFA-134a driven salbutamol sulfate metered-dose inhaler:formulation screening and respiratory tract absorption in rats[J]. Journal of China Pharmaceutical University, 2009, 40(4): 332-336. |
[7] | Optimizing Composition and Preparation of TMC-Coated Insulin Liposomes[J]. Journal of China Pharmaceutical University, 2003, (4): 32-36. |
[8] | Study on Optimize the Preparation and Formulation of Nimodipine-Containing Nanoliposome[J]. Journal of China Pharmaceutical University, 2003, (1): 27-30. |
[9] | Preparation of Compound Lonicera japonica Effervescent Spray[J]. Journal of China Pharmaceutical University, 2002, (4): 39-41. |
[10] | Preparation and Release Properties of Felodipine Sustained-release Capsules[J]. Journal of China Pharmaceutical University, 2000, (3): 19-21. |